Chris Freeman, Chief Commercial Officer at Guardant Health, Inc. (GH), sold 61,182 shares at $102.31 ($6.3M) on 2025-12-05, disclosed to the SEC on 2025-12-08.
Open-market sale of $6.3M GH by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.40 | 4,084 | $414K | 6.6% |
| 2 | $101.40 | 4,084 | $414K | 6.6% |
| 3 | $101.43 | 478 | $48K | 0.8% |
| 4 | $102.09 | 11,969 | $1.2M | 19.4% |
| 5 | $102.09 | 11,969 | $1.2M | 19.4% |
| 6 | $102.31 | 744 |
| $76K |
| 1.2% |
| 7 | $102.31 | 744 | $76K | 1.2% |
| 8 | $103.25 | 3,414 | $352K | 5.6% |
| 9 | $103.25 | 3,414 | $352K | 5.6% |
| 10 | $103.48 | 372 | $38K | 0.6% |
| 11 | $103.97 | 6,555 | $682K | 10.8% |
| 12 | $103.97 | 6,555 | $682K | 10.8% |
| 13 | $104.10 | 244 | $25K | 0.4% |
| 14 | $105.99 | 400 | $42K | 0.7% |
| 15 | $106.63 | 228 | $24K | 0.4% |
| 16 | $106.71 | 2,964 | $316K | 5.0% |
| 17 | $106.71 | 2,964 | $316K | 5.0% |
| Total | $103.04 avg | 61,182 | $6.3M | 100% |
| Filing → |